Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care.

NCT03495089 is registered in ClinicalTrials.gov with Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina as lead sponsor.

NCT NCT03495089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03495089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care.
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
September 30, 2018
Enrollment
147 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, neuropathy, diabetic